This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Checking in with a prescriber of Apellis' Syfovre in treating Geographic Atrophy (GA)

Ticker(s): APLS

Who's the expert?

Institution: Stanford University

  • Adjunct Clinical Assistant Professor of Ophthalmology at Stanford University; fellowship trained at Wills Eye.
  • Specializes in the medical and surgical management of diseases affecting the retina, with a clinical expertise in macular degeneration, diabetic retinopathy, retinal detachment, macular hole, macular pucker/epiretinal membranes, and uveitis and considers himself an expert in anti-complement therapies.
  • Research interests include novel retinal imaging platforms and technology in ophthalmology such as emerging Al and deep learning platforms.

Interview Questions
Q1.

Roughly how many patients do you manage with Geographic Atrophy?

Added By: dami_admin
Q2.

How many patients have you prescribed Syfovre to?

Added By: dami_admin
Q3.

On a scale from 1-10 (10 being extremely excited) where would you rate your level of excitement for Syfovre?

Added By: dami_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.